Our Technology
HealthRegen is an Australian stem cell and diabetes regenerative medicine company, fully committed to developing a curative mature beta-cell therapy to people with type 1 diabetes thus regenerating their health.
HealthRegen embraces collaboration opportunities with other willing biotechnology and pharmaceutical companies, as well as world-renowned research and clinical institutions all over the world to develop its solutions, platform and products for diabetic sufferers.
Mature Beta Cell Therapy (BCT)
BCT is currently developed as a curative therapy for type 1 diabetes and a subset of insulin-dependent type 2 diabetes.
Intellectual Property
Issued patents, expanded know-how, unpublished therapeutics-related datasets and a vast diabetes stem cell therapy database.
Research Publications
Collaborations
HealthRegen warmly embraces collaborations with other willing biotechnology and pharmaceutical companies, as well as world-renowned research and clinical institutions all over the world to develop her solutions, platform and products for people suffering from diabetes.